Eylward Susan sold $4K of IMNN
Eylward Susan (General Counsel and Corp Sec) sold 2,150 shares of Imunon, Inc. (IMNN) at $1.78 on 2026-07-20.
How this was made
The 30-second read
Why it matters
The newest fact is the specific open-market sale details by the issuer’s general counsel, including share count, price, and post-transaction holdings.
Market read
Traders may note insider selling, but the disclosed transaction value is small and lacks accompanying fundamental catalysts.
What to watch
The absence of a 10b5-1 plan could raise scrutiny, but the filing provides no context for motive or whether other insiders are selling/buying around the same time.
Background
The article is an SEC Form 4 insider transaction disclosure for Imunon, Inc. (IMNN).
Ticker impact
SEC Form 4 shows IMUNON general counsel sold 2,150 shares on 2026-07-20 at $1.7816, totaling $3,830.44.
Likely limited near-term impact; treat as low-signal unless repeated or paired with other negative disclosures.
The filing is primary-source but the transaction size is small and does not include new company fundamentals, guidance, or regulatory/operational events.
Market effects
No clear sector read-through from a small insider sale filing.
None.
None.
Counterpoint
Insider sales can be for diversification or personal liquidity needs and may not reflect negative expectations, especially for small dollar amounts.
Key entities
- issuerImunon, Inc.
Company whose insider transaction is disclosed on Form 4.
- insiderEylward Susan
General Counsel and Corp Sec who sold 2,150 shares.
